Dr Reddys
Dr Reddy’s Q3 net profit up 77 pc at Rs 1,247 cr
Hyderabad: Generic Drug maker, Dr Reddy’s Laboratories’ on Wednesday reported a 77 per cent increase in consolidated net profit to Rs 1,247 crore in the third quarter ended December 2022 as against Rs 706 crore in the corresponding quarter in the previous year.
The total revenue from operations was up by 27 per cent to Rs 6,770 crore as against Rs 5,319.7 crore, in the corresponding quarter in 2021, Hyderabad-based pharmaceutical giant said in a release here.
For the first nine-months ended December, 2022, the Pharma’s net profit rose by 56 percent to Rs 3,548 crore while revenues increased by 14 per cent to Rs 18,291 crore.
Commenting on the results, Co-chairman and Managing Director, G V Prasad said “Our strong financial performance was supported by growth in the US and the Russia markets.
He said we continue to strengthen our development pipeline to reach more patients globally.”
(With UNI inputs)
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
